B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 860 KRW 1.89% Market Closed
Market Cap: 495.6B KRW
Have any thoughts about
BioNote Inc?
Write Note

Intrinsic Value

The intrinsic value of one BioNote Inc stock under the Base Case scenario is 4 469.88 KRW. Compared to the current market price of 4 860 KRW, BioNote Inc is Overvalued by 8%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
4 469.88 KRW
Overvaluation 8%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation History
BioNote Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
BioNote Inc
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for BioNote Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about BioNote Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

4 860 KRW
+1.89%
+1.89%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

BioNote Inc
KR
Biotechnology
Market Cap
496B KRW
IPO
Dec 22, 2022
Employees
-
Korea
Market Cap
496B KRW
Industry
Biotechnology
IPO
Dec 22, 2022
Company Overview
Loading...
Economic Moat
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about BioNote Inc

Provide an overview of the primary business activities
of BioNote Inc.

What unique competitive advantages
does BioNote Inc hold over its rivals?

What risks and challenges
does BioNote Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for BioNote Inc.

Provide P/S
for BioNote Inc.

Provide P/E
for BioNote Inc.

Provide P/OCF
for BioNote Inc.

Provide P/FCFE
for BioNote Inc.

Provide P/B
for BioNote Inc.

Provide EV/S
for BioNote Inc.

Provide EV/GP
for BioNote Inc.

Provide EV/EBITDA
for BioNote Inc.

Provide EV/EBIT
for BioNote Inc.

Provide EV/OCF
for BioNote Inc.

Provide EV/FCFF
for BioNote Inc.

Provide EV/IC
for BioNote Inc.

Show me price targets
for BioNote Inc made by professional analysts.

What are the Revenue projections
for BioNote Inc?

How accurate were the past Revenue estimates
for BioNote Inc?

What are the Net Income projections
for BioNote Inc?

How accurate were the past Net Income estimates
for BioNote Inc?

What are the EPS projections
for BioNote Inc?

How accurate were the past EPS estimates
for BioNote Inc?

What are the EBIT projections
for BioNote Inc?

How accurate were the past EBIT estimates
for BioNote Inc?

Compare the revenue forecasts
for BioNote Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of BioNote Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of BioNote Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of BioNote Inc compared to its peers.

Compare the P/E ratios
of BioNote Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing BioNote Inc with its peers.

Analyze the financial leverage
of BioNote Inc compared to its main competitors.

Show all profitability ratios
for BioNote Inc.

Provide ROE
for BioNote Inc.

Provide ROA
for BioNote Inc.

Provide ROIC
for BioNote Inc.

Provide ROCE
for BioNote Inc.

Provide Gross Margin
for BioNote Inc.

Provide Operating Margin
for BioNote Inc.

Provide Net Margin
for BioNote Inc.

Provide FCF Margin
for BioNote Inc.

Show all solvency ratios
for BioNote Inc.

Provide D/E Ratio
for BioNote Inc.

Provide D/A Ratio
for BioNote Inc.

Provide Interest Coverage Ratio
for BioNote Inc.

Provide Altman Z-Score Ratio
for BioNote Inc.

Provide Quick Ratio
for BioNote Inc.

Provide Current Ratio
for BioNote Inc.

Provide Cash Ratio
for BioNote Inc.

What is the historical Revenue growth
over the last 5 years for BioNote Inc?

What is the historical Net Income growth
over the last 5 years for BioNote Inc?

What is the current Free Cash Flow
of BioNote Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for BioNote Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
BioNote Inc

Current Assets 467.1B
Cash & Short-Term Investments 416.7B
Receivables 22.9B
Other Current Assets 27.5B
Non-Current Assets 1.2T
Long-Term Investments 1.1T
PP&E 90.3B
Intangibles 9.7B
Other Non-Current Assets 1.8B
Current Liabilities 18B
Accounts Payable 3.3B
Accrued Liabilities 1.5B
Other Current Liabilities 13.3B
Non-Current Liabilities 32B
Long-Term Debt 2.7B
Other Non-Current Liabilities 29.3B
Efficiency

Earnings Waterfall
BioNote Inc

Revenue
95.1B KRW
Cost of Revenue
-48.1B KRW
Gross Profit
47B KRW
Operating Expenses
-32.5B KRW
Operating Income
14.5B KRW
Other Expenses
67.1B KRW
Net Income
81.7B KRW

Free Cash Flow Analysis
BioNote Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

BioNote Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Exceptional Revenue Growth Forecast
Positive Gross Profit
Positive Net Income
51/100
Profitability
Score

BioNote Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

BioNote Inc's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

BioNote Inc's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
BioNote Inc

Wall Street analysts forecast BioNote Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BioNote Inc is 5 814 KRW with a low forecast of 5 757 KRW and a high forecast of 5 985 KRW.

Lowest
Price Target
5 757 KRW
18% Upside
Average
Price Target
5 814 KRW
20% Upside
Highest
Price Target
5 985 KRW
23% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BioNote Inc?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BioNote Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one BioNote Inc stock?

The intrinsic value of one BioNote Inc stock under the Base Case scenario is 4 469.88 KRW.

Is BioNote Inc stock undervalued or overvalued?

Compared to the current market price of 4 860 KRW, BioNote Inc is Overvalued by 8%.

Back to Top